You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial

 

Online download statistics by month:

Online download statistics by month: August 2021 to February 2026

AbstractFullPdf
Aug 2021450450154
Sep 202116216365
Oct 202116716635
Nov 202112812824
Dec 202112212216
Jan 202210810924
Feb 2022555528
Mar 2022778233
Apr 2022768219
May 2022848532
Jun 2022747423
Jul 2022656613
Aug 2022909025
Sep 2022798124
Oct 2022969826
Nov 2022757822
Dec 2022777728
Jan 2023777716
Feb 2023595920
Mar 2023485025
Apr 2023626343
May 2023474824
Jun 2023474718
Jul 2023696921
Aug 2023989817
Sep 2023474710
Oct 2023939421
Nov 2023808017
Dec 2023626223
Jan 2024555623
Feb 2024727216
Mar 202411011087
Apr 202417317338
May 2024626125
Jun 2024646419
Jul 202415315331
Aug 2024383714
Sep 2024434322
Oct 2024596020
Nov 2024616321
Dec 2024818115
Jan 202518718728
Feb 202512312319
Mar 2025707024
Apr 202523723724
May 202512913025
Jun 202530931025
Jul 2025110
Feb 2026110
Total480248321322